Atomoxetine HCl

CAS 82248-59-7
Back to the Catalog Contact us about this API

General Information

Atomoxetine is an orally administered medication used as part of a total treatment program to increase the ability to pay attention and decrease impulsiveness and hyperactivity in children and adults with ADHD.

About the API

Technology Synthetic
Therapeutic category Neurology-Psychiatry
Available formulations Oral Liquid Oral Solid
Regulations Canada DMF Flag Canada DMF EU DMF Flag EU DMF Korea DMF Flag Korea DMF US DMF Flag US DMF

Related API products

Paliperidone Palmitate 199739-10-1 Desvenlafaxine Fumarate 93414-01-1 Desvenlafaxine Base 93413-62-8 Buprenorphine HCl 53152-21-9

The information detailed herein, including that with regard to active pharmaceutical ingredients , their use in treatments and possible mechanism(s) of action, was all obtained from public sources.

For more information on our services and products – including product suitability, intended uses and current availability – please contact Teva api Customer Service. CAS Registry Number is a Registered Trademark of the American Chemical Society. This webpage and any reference to the above product is to be read within the meaning and terms of the Legal Notes.

This site uses cookies (unless you have disabled them) to give you a better and personalized browsing experience and targeted ads.
By continuing your visit on this website, you agree to the use of Cookies on your device. Find out more in our Privacy Policy